Compound Solutions, Inc. Announces TeaCrine® Clinical Trial That Delivers Groundbreaking Results

Share Article

The largest in-human theacrine trial to date shows no habituation or side effects—all in an effective ingredient poised to revolutionize energy and performance.

Compound Solutions, Inc., exclusive global distributor of patent-protected TeaCrine®, today announced several groundbreaking findings in the largest in-human clinical trial ever performed on theacrine, the generic name for branded TeaCrine®. TeaCrine is the newest, most innovative ingredient in the energy and cognitive markets.

Performed at a leading U.S. university with a well-established nutritional sciences research program, the 8-week, 60-subject study set out to answer different questions about the safety and habituation effects of longer term TeaCrine use. The findings were: 1) an excellent safety profile, as measured by repeated measurements across a broad spectrum of clinical safety markers (i.e. heart rate, blood pressure, EKG, lipid profiles, hematologic blood counts, biomarkers of liver/kidney/immune function), 2) no attenuation (habituation) of efficacy nor desensitization as measured by repeated measurements of energy, focus, concentration, anxiety, motivation to exercise, etc. These outcomes were measured prior to daily dosing, when you would otherwise expect to observe a decline in these measures over the 8 weeks of repetitive use.

The 60-subject TeaCrine study also validated previous human research conducted at the Center for Applied Health Sciences, and confirmed what Matt Titlow, CEO of Compound Solutions has known for a long time. “The results speak for themselves,” said Titlow. “TeaCrine is the most unique and innovative ingredient I’ve come across in more than a decade, and now its benefits have been validated.”

While the results are positive, they aren’t surprising. Previous research recently on Pubmed.gov showed that TeaCrine increased feelings of energy, reduced fatigue, and had strong effects on improving focus, concentration, motivation to exercise and libido.

“In a regulatory environment where every energy ingredient is scrutinized, we are proud to say we’ve invested a very large amount of money into the safety, efficacy, sensory, IP and comprehensive regulatory platforms of TeaCrine,” Titlow said. “But that’s just the start. We’re continuing to broaden TeaCrine’s potential applications and validate new claims.”

Leading global sport nutrition brands such as Cellucor®, Muscle Pharm®, ProSupps®, Purus Labs®, USN Sports Nutrition, Nutrex® and others currently in development have all licensed the IP-protected ingredient. “We see this as a revolution in energy,” said Titlow. “In a market full of questions, TeaCrine® is the clear answer. It’s safe, compliant, and it works. And brands are lining up to get it in their products.”. The study results, combined with the overwhelming, positive feedback, further indicate that TeaCrine® is delivering the mental and performance edge with the unmatched safety the market has been searching for. Instead of filling their shelves with poorly tested, ineffective, or allegation-riddled ingredients, TeaCrine® gives brands an new alternative to showcase their products where they belong—on the field and in the gym instead of collecting dust on their shelves.

About Compound Solutions, Inc.

Compound Solutions, Inc. is the go-to company representing and distributing unique, patented nutraceutical ingredients for the sports nutrition, functional food and nutritional supplement markets. Compound Solutions is the exclusive global supplier of TeaCrine®.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Matthew Titlow
Visit website